Slc13a5 icd10
WebThe SLC13 family comprises five genes (SLC13A1, SLC13A2, SLC13A3, SLC13A4, and SLC13A5) encoding structurally related multi-spanning transporters (8-13 transmembrane domains) with orthologues found in prokaryotes and eukaryotes. Mammalian SLC13 members mediate the electrogenic Na(+)-coupled anion co … WebSep 14, 2024 · SLC13A5 NaCT citrate hepatocellular carcinoma neurons lipogenesis zinc Introduction Citrate serves as a critical substrate for biosynthesis, acetylation, and the regeneration of NAD (P)H. Within mitochondria, citrate is synthesized by citrate synthase and metabolized in the tricarboxylic acid (TCA) cycle to support bioenergetics.
Slc13a5 icd10
Did you know?
WebMar 21, 2024 · The SLC13A5 gene encodes a sodium-dependent citrate transporter protein, NaCT, that is highly expressed in the liver, brain, bone, teeth, and reproductive organs, and in other organs at much lower levels ( Pajor et al., 2001; Inoue, et al., 2002; Gopal et al., 2007; Kumar et al., 2024 ). WebFeb 17, 2024 · Slc13a5-knockout mice have increased hepatic mitochondrial biogenesis, higher lipid oxidation and energy expenditure, and reduced lipogenesis, which together …
WebOct 1, 2024 · E72.09 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2024 edition of ICD-10-CM E72.09 became effective on October 1, 2024. This is the American ICD-10-CM version of E72.09 - other … WebSLC13A5 as a novel pharmacologic target for metformin and its relevance to the antidiabetic efficacy of the drug Vadivel Ganapathy, PhD Metformin is the first-line treatment for type 2 diabetes. Inhibition of hepatic gluconeogenesis is the primary contributor to its anti-diabetic effect.
WebSLC13A5 is a tricarboxylate plasma transporter with a preference for citrate. [5] Clinical significance [ edit] In 2014, by means of exome sequencing it was determined that a genetic mutation of the SLC13A5 gene is the cause of a rare citrate transporter disorder. [6] WebDec 10, 2024 · The SLC13A5 mutation in nine epilepsy patients were identified. The drug acetazolamide (a carbonic anhydrase inhibitor) and the atypical anti-seizures drugs decreased the seizures in four patients. Also, it was noticed that the ketogenic diet and fasting worsened the symptoms.
WebBI01383298 is a potent inhibitor of the human solute carrier SLC13A5, also known as sodium-coupled citrate transporter (hNaCT). Its potency and selectivity is improved over prior tools, even over related family members such as …
WebThe SLC13 family comprises five genes (SLC13A1, SLC13A2, SLC13A3, SLC13A4, and SLC13A5) encoding structurally related multi-spanning transporters (8-13 transmembrane … groove credit card machineWebMar 21, 2024 · SLC13A5 (Solute Carrier Family 13 Member 5) is a Protein Coding gene. Diseases associated with SLC13A5 include Developmental And Epileptic Encephalopathy … groove coverage - on the radioWebApr 14, 2024 · PMCID: PMC9032242 DOI: 10.3390/metabo12040351 Abstract Though biallelic variants in SLC13A5 are known to cause severe encephalopathy, the mechanism … groove credit card processingWebAug 18, 2024 · SLC13A5 citrate transporter disorder is a recently identified autosomal recessive disorder. Patients with SLC13A5 citrate transporter disorder are initially … filetype pdf bitcoinWebICD-10. ICD-10-CM Codes. Injury, poisoning and certain other consequences of external causes. Injuries to the abdomen, lower back, lumbar spine, pelvis and external genitals. … file type:pdf book title: gurjiafWebSep 14, 2024 · SLC13A5 was expressed in both cell types, and exogenous citrate was imported and metabolized to fatty acids and TCA cycle intermediates. However, citrate … filetypepdf bobs discount furnitureWebSep 18, 2015 · SLC13A5 encodes a high affinity sodium-dependent citrate transporter, which is expressed in the brain. Neurons are considered incapable of de novo synthesis of … groove coverage the end